-

Medical Devices

  • Share Share this page

FDA/AAO/AAO/AOA/CLAO Workshop: Microbiological Testing for Contact Lens Care Products, January 22-23, 2009

 


 Meeting Materials


 Date, Time and Location

The meeting was held on January 22 - 23, 2009 from 8:00 a.m. to 5:00 p.m. at the following location:

Food and Drug Administration
Building 2
10903 New Hampshire Ave.
Silver Spring , MD 20993

Return to Top


Agenda & Presentations

All presentations are in PowerPoint format unless otherwise noted. For FDA and CDC materials, captions and alternative text are available in the speaker notes.

Date/Time Agenda
January 22, 2009
8:00 – 8:15
Welcome
Malvina Eydelman, MD, FDA
Jonathan Sackner-Bernstein, MD, FDA
8:15 – 8:30

DISINFECTION EFFICACY TESTING - Acanthamoeba
Thomas Steineman, MD, Moderator

Disinfection efficacy testing and Acanthamoeba-FDA perspective
Myra Smith, MHS, FDA

8:30 – 9:10 Acanthamoeba keratitis update
Jonathan Yoder, MD, CDC
Charlotte Joslin, OD
9:10 – 9:30 Biology and Immunology of Acanthamoeba keratitis
Jerry Y. Niederkorn, PhD, University of Texas Southwestern Medical Center
9:30 – 10:10 Test Methods to Evaluate Efficacy against Acanthamoeba (10 min presentation + 10 min Q&A)
Simon Kilvington, PhD, Advanced Medical Optics
Megan Shoff, MS, Ohio State University
10:10 – 10:20 BREAK
10:20 – 11:40 Test Methods cont'd
Claude Anger, MS
Govinda Visvesvara, PhD, CDC
Hassan Alizadeh, PhD, University of Texas Southwestern Medical Center
Masaki Imayasu, PhD, Menicon
11:40 – 12:00 Instructions for Breakout Groups
James Saviola, OD; Capt USPHS; FDA; Facilitator
12:00 – 1:00 LUNCH
1:00 – 2:30 Breakout Groups Discuss Questions
2:30– 3:00 BREAK
3:00 – 4:30 Breakout Group Discussion Continues
4:30 Breakout Group Discussion Ends - ADJOURNMENT
 
January 23, 2009
8:00 – 10:00
Facilitated Discussion of Breakout Groups’ Recommendations
James Saviola, OD; Capt USPHS; FDA; Facilitator
10:00 – 10:15 BREAK
10:15 – 10:30

“REAL WORLD” DISINFECTION EFFICACY TESTING 
Thomas Steineman, MD, Moderator

FDA guidance on disinfection efficacy testing – history and background
Myra Smith, MHS FDA

10:30 – 12:00 Disinfection Efficacy Methodology Presentations (20 min presentation + 10 min Q&A)
Mary Mowrey McKee, PhD, CIBA Vision
Mahmoud Ghannoum, PhD, Case Western Reserve University
Mark Willcox, PhD, Vision Cooperative Research Centre
12:00 – 1:00 LUNCH
1:00 – 3:00 Disinfection Efficacy Methodology Presentations, cont’d
Roya Borazjani, PhD, Alcon
Simon Kilvington, PhD, AMO
Donald Ahearn, PhD, Georgia State University (PDF)
Sue Norton, MS, Bausch & Lomb
3:00 – 3:15 BREAK
3:15 – 4:15 Disinfection Efficacy Methodology Presentations, cont’d
Ralph Stone, Ph.D
Charles Clavet, MS, FDA
4:15 – 5:00

Closing Remarks

FDA
Malvina B. Eydelman, M.D.

American Academy of Ophthalmology
Elmer Y. Tu, MD

American Academy of Optometry
American Optometric Association
William J. Benjamin, OD, MS, PhD

Contact Lens Association of Ophthalmologists
H. Dwight Cavanagh, MD
Thomas L. Steineman, MD

5:00 ADJOURNMENT

Return to Top


Contacts

The workshop organizers may be contacted at:

Daryl L. Kaufman, M.A.
Center for Devices and Radiological Health
U.S. Food and Drug Administration
9200 Corporate Blvd (HFZ-460)
Rockville, Maryland 20850
240-276-4200
FAX: 240-276-4234,
e-mail: Daryl.Kaufman@fda.hhs.gov

Marc W. Robboy, OD
Center for Devices and Radiological Health
U.S. Food and Drug Administration
9200 Corporate Blvd (HFZ-460)
Rockville, Maryland 20850
240-276-4232
FAX: 240-276-4111,
e-mail: Marc.Robboy@fda.hhs.gov

    
-
-
-
-
-